The clinical study of the budesonide/formoterol combination drug additional dosage in the perioperative period in a lung cancer patient with COPD.
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2014
At a glance
- Drugs Budesonide/formoterol (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease; Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Aug 2013 New trial record